SIUOxford hosted an eye-opening two part event focused on the UK-China collaboration ecosystem for science and technology. In Part I, our three invited speakers addressed why there is a good match between the UK and China and presented two examples of start-ups that have benefitted from such collaboration. Read here for more..
Is patent drafting an art form and are patents an underused resource for scientists? What criteria must be satisfied to be granted one? Read here to also learn about pivotal patent cases in biotechnology and the consequences for the patenting culture in this industry.
Progress in modern scientific research is accomplished primarily by collaborative teamwork. In this piece that got shortlisted for the SIU-Naturejobs writing competition, University of Oxford PhD student Sofia D'Abrantes discusses the advantages of academic-industrial collaborations, her advice to foment successful partnerships and what you can do to encourage them.
The first SIUConversations Oxford session on February 21st introduced the complicated world of intellectual property (IP) and featured the eminent patent attorney Philip Webber. Dr. Webber is currently a qualified chartered patent attorney, a European patent attorney, and a partner at the highly reputable international patent and trade mark attorneys, Dehns. In this article we bring you a summary of his presentation that highlighted a number of important questions to ponder when trying to patent an invention.
At the 3rd session of our education programme SIU360, we welcomed Steven Zimmer as our speaker in Oxford. Steven talked about the strategies one should be aware of when starting a new business, risks associated with start-ups and how to find the balance between one's passion in science and the market and much more! Here is the summary of what Steven told our participants on November 15.
'Open Innovation' is one of those terms that appear often in business-related news and discussions but don't reveal their definition in the first instance. In this article, we discuss what it is and what it's not, the risks and advantages associated with it while highlighting examples where it is used by companies.
James explores the origins, development, scientific background and subsequent business activities surrounding the emergence of this tremendously powerful gene editing technique.